Asahi Kasei Draws the Line on HMD: Strategic Exit from Hexamethylenediamine Production Signals Portfolio Refocus

In a decisive move to sharpen its competitive edge, Asahi Kasei Corporation has announced it will cease production of hexamethylenediamine (HMD)—a key chemical intermediate—by April 2027. The decision, revealed on December 5, 2025, is not a retreat from performance materials, but a calculated step in the Japanese conglomerate’s broader strategy to optimize its product portfolio, improve capital efficiency, and bolster long-term profitability.

HMD, traditionally used as a building block for polyamide 66 (PA66), hexamethylene diisocyanate (HDI), and epoxy curing agents, has faced mounting pressure from shifting market dynamics, intensifying global competition, and rising capital requirements. After a thorough review of these factors, Asahi Kasei concluded that continuing HMD production no longer aligned with its strategic priorities.

Crucially, the exit is surgically precise: it will not disrupt Asahi Kasei’s downstream operations. The company confirmed that its PA66 resin and fiber manufacturing in Nobeoka, Miyazaki, as well as its HDI and derivative production in Hyūga, Miyazaki, will continue uninterrupted. This is possible because Asahi Kasei sources HMD for these units through integrated processes or alternative supply arrangements—ensuring business continuity while shedding non-core upstream exposure.

Equally notable is the company’s commitment to its workforce. All employees affected by the HMD shutdown will be reassigned internally, reflecting Asahi Kasei’s long-standing emphasis on social responsibility and talent retention.

Financially, the impact is expected to be negligible. The company stated that the discontinuation will have “minimal effect” on its consolidated earnings forecast, underscoring that HMD had become a marginal contributor amid evolving margins and demand patterns—particularly as PA66 markets face volatility from automotive sector slowdowns and raw material price swings.

This move mirrors a wider trend among global chemical firms: exiting commoditized intermediates to focus on high-value, differentiated specialties. For Asahi Kasei—already a leader in engineering plastics, healthcare, and electronics—the HMD exit clears the deck for deeper investment in growth arenas like sustainable polymers, battery materials, and advanced filtration.

By stepping back from hexamethylenediamine, Asahi Kasei isn’t shrinking—it’s streamlining. And in an era where capital discipline defines resilience, that may be the smartest chemistry of all.